Twist Bioscience (TWST) Invested Capital (2018 - 2026)

Twist Bioscience (TWST) has reported Invested Capital for 8 consecutive years, with $460.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Invested Capital fell 6.58% year-over-year to $460.7 million in Q2 2026; TTM through Jun 2026 was $460.7 million, a 6.58% decrease from a year earlier, with the FY2025 full-year figure at $488.0 million, up 3.23% from the prior year.
• Invested Capital was $460.7 million for Q2 2026 at Twist Bioscience, down from $470.1 million in the prior quarter.
• Over five years, Invested Capital peaked at $863.4 million in Q1 2022 and troughed at $455.1 million in Q1 2025.
• A 4-year average of $568.7 million and a median of $472.7 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital surged 39.85% in 2022 and dropped 6.58% in 2026, its largest moves.
• Over 4 years, Invested Capital stood at $789.4 million in 2022, then tumbled by 40.34% to $470.9 million in 2024, then grew by 0.03% to $471.1 million in 2025, then retreated by 2.2% to $460.7 million in 2026.
• The last three Invested Capital figures came in at $460.7 million (Q2 2026), $470.1 million (Q1 2026), and $471.1 million (Q4 2025), per Business Quant data.